Clinical Study of Therapeutic Immunological Agent for EBV Lymphoproliferative Diseases
Clinical Study of Therapeutic Immunological Agent for EBV Lymphoproliferative Diseases
Not yet recruiting · NCT06666153 · Registry updated 2024-10-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study of Therapeutic Immunological Agent for EBV Lymphoproliferative Diseases | Hemic and Lymphatic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, disease, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoproliferative syndrome, syndromic disease | Not yet recruiting | Phase 1 | 2024-10-30 | NCT06666153 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| West China Hospital | 359 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| West China Hospital | Chengdu | China | 21 |